SCHEMBL28930243

SCHEMBL28930243

O=C(O)Nc1ccc(F)c(NC(=O)c2cccc(C(F)(F)F)c2)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
PTGS1 P23219 3/20 0.55
GAA P10253 1/20 0.55
KCNK3 O14649 2/20 0.54
P2RX1 P51575 1/20 0.53
ALDH1A1 P00352 1/20 0.53
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
RAB9A P51151 2/20 0.52
HTT P42858 1/20 0.52
MAPT P10636 3/20 0.51
KCNK9 Q9NPC2 1/20 0.51
NPC1 O15118 1/20 0.51
KDR P35968 2/20 0.51
CLK1 P49759 1/20 0.50
RXFP1 Q9HBX9 1/20 0.48
KCNJ11 Q14654 1/20 0.47
KCNQ3 O43525 1/20 0.47
KCNQ2 O43526 1/20 0.47
KCNE1 P15382 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20577767 0.84 RXFP1 (0.53) LMNAPTGS1GAAKCNK3P2RX1
SCHEMBL20577803 0.82 PTGS1 (0.64) LMNAPTGS1GAAKCNK3P2RX1
SCHEMBL19233247 0.82 PTGS1 (0.52) LMNAPTGS1GAAKCNK3P2RX1
SCHEMBL19233515 0.80 PTGS1 (0.68) LMNAPTGS1GAAKCNK3P2RX1
SCHEMBL30739971 0.78 HDAC1 (0.46) LMNAPTGS1GAAKCNK3P2RX1
SCHEMBL28317667 0.77 MEN1 (0.50) KCNK3ALDH1A1KMT2AMEN1RAB9A
SCHEMBL28316859 0.77 MEN1 (0.47) LMNAKCNK3ALDH1A1KMT2AMEN1
SCHEMBL28668959 0.76 LMNA (0.83) LMNAPTGS1GAAKCNK3P2RX1
SCHEMBL30739787 0.76 PTGS1 (0.65) LMNAPTGS1GAAKCNK3P2RX1
SCHEMBL28316754 0.76 HDAC1 (0.46) GAAP2RX1ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071543-B Pyridine derivatives inhibiting RAF kinase and vascular endothelial growth factor receptor, process for their preparation, pharmaceutical compositions containing them and their use 三进制药株式会社 2021-07-16 CN disclosed